Portugal

New lab at FMUP will detect cancer and Alzheimer's

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 19/10/2026, 16:01:25 UTC.

Briefings

A FMUP is launching a new laboratory to detect cancer and Alzheimer's disease using real-time tumor classification and blood-based Alzheimer's analysis, funded by the PRR. The facility aims to provide early diagnosis through innovative biomarker technologies.

Key points

• The Novo laboratory will utilize real-time tumor classification to detect cancer and blood-based analysis to screen for Alzheimer's disease.
• The project is funded by the PRR and aims to provide early diagnosis through innovative biomarker technologies.

Context

A new laboratory at FMUP will employ real-time tumor classification and blood-based Alzheimer's screening funded by the PRR.

Limitations

Evidence is limited to a single sentence describing the laboratory's capabilities and funding source without details on operational status, expected results, or specific patient outcomes.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 20/10/2026, 00:37:24 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeifjrtpjswk2z7a6u4vbsvizzqwn2lwmrno67vlicata34bp3djji4